InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Benton Susan, Director. Insider active across 1 companies, notably Ocuphire Pharma, Inc.. Aggregated, 9 filings have been logged. Total volume traded: €154k. The latest transaction was disclosed on 2 September 2021 — Acquisition. Regulator: SEC (Form 4). All data is openly available.
Declarations9 total
3,395 shares
Common Stock
SEC:0001140361-22-013064:0·
2,949 shares
Common Stock
SEC:0001140361-22-000658·
2,949 shares
Common Stock
SEC:0001140361-22-000658:0·
2,135 shares
Common Stock
SEC:0001140361-21-033449·
2,135 shares
Common Stock
SEC:0001140361-21-033449:0·
€76,95920,000 shares@ €3.8479100.0% of flow
Common Stock
SEC:0001140361-21-030364·
Ideal exit: 30 May 2022 (T+270)
€76,95920,000 shares@ €3.847950.0% of flow
Common Stock
SEC:0001140361-21-030364:0·
Ideal exit: 30 May 2022 (T+270)
2,083 shares
Common Stock
SEC:0001140361-21-023335·
2,083 shares
Common Stock
SEC:0001140361-21-023335:0·
9 of 9 declarations
About Benton Susan
Susan Benton is a Director at Ocuphire Pharma, Inc. In this role, she participates in the governance of the company and strategic decision-making. Benton brings valuable expertise to the board through her experience in the pharmaceutical sector. Her commitment to innovation and corporate responsibility is essential in guiding Ocuphire's initiatives. She collaborates with other board members to ensure the strategic direction of the company.
